Orchard Therapeutics Plc (ORTX) reported Q3 EPS of ($0.37), $0.14 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $5.78 million versus the consensus estimate of $4.41 million.
Orchard Therapeutics Plc (ORTX) reported Q3 EPS of ($0.37), $0.14 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $5.78 million versus the consensus estimate of $4.41 million.